DK1051179T3 - Anti-estrogen- plus progestin-holdige orale kontraceptiva - Google Patents

Anti-estrogen- plus progestin-holdige orale kontraceptiva

Info

Publication number
DK1051179T3
DK1051179T3 DK98956525T DK98956525T DK1051179T3 DK 1051179 T3 DK1051179 T3 DK 1051179T3 DK 98956525 T DK98956525 T DK 98956525T DK 98956525 T DK98956525 T DK 98956525T DK 1051179 T3 DK1051179 T3 DK 1051179T3
Authority
DK
Denmark
Prior art keywords
oral contraceptives
containing oral
estrogen plus
plus progestin
progestin
Prior art date
Application number
DK98956525T
Other languages
English (en)
Inventor
Michael Jay Gast
Christopher Paul Miller
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1051179T3 publication Critical patent/DK1051179T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98956525T 1997-11-06 1998-11-04 Anti-estrogen- plus progestin-holdige orale kontraceptiva DK1051179T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96508397A 1997-11-06 1997-11-06
PCT/US1998/023427 WO1999024027A2 (en) 1997-11-06 1998-11-04 Anti-estrogen plus progestin containing oral contraceptives

Publications (1)

Publication Number Publication Date
DK1051179T3 true DK1051179T3 (da) 2005-10-31

Family

ID=25509417

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956525T DK1051179T3 (da) 1997-11-06 1998-11-04 Anti-estrogen- plus progestin-holdige orale kontraceptiva

Country Status (28)

Country Link
EP (1) EP1051179B1 (da)
JP (1) JP2001522798A (da)
CN (1) CN1278732A (da)
AR (1) AR016667A1 (da)
AT (1) ATE304359T1 (da)
AU (2) AU760540B2 (da)
BG (1) BG104451A (da)
BR (1) BR9813982A (da)
CA (1) CA2307210A1 (da)
CZ (1) CZ294155B6 (da)
DE (1) DE69831605T2 (da)
DK (1) DK1051179T3 (da)
EA (1) EA200000492A1 (da)
EE (1) EE04092B1 (da)
ES (1) ES2246541T3 (da)
GE (1) GEP20043290B (da)
HR (1) HRP20000269A2 (da)
HU (1) HUP0100293A3 (da)
ID (1) ID24568A (da)
IL (1) IL135621A0 (da)
NO (1) NO20002167L (da)
NZ (1) NZ503890A (da)
PL (1) PL340623A1 (da)
SK (1) SK6482000A3 (da)
TR (1) TR200001268T2 (da)
UA (1) UA68365C2 (da)
WO (1) WO1999024027A2 (da)
ZA (1) ZA9810136B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AP1424A (en) * 1998-05-15 2005-06-06 Wyeth Corp 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
BR0013943A (pt) * 1999-09-13 2002-05-14 American Home Prod Conjugados de glicopiranosìdeos de 2-(4-hidróxi-fenil)-1-[4-(2-amin-1-il-etóxi)-benzil]-1h-indo l-5-óis
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
CN1599606A (zh) 2001-07-31 2005-03-23 辉瑞产品公司 包含雌激素激动剂/拮抗剂、雌激素与孕激素组合的药物组合物、试剂盒和方法
PT1809602E (pt) 2004-10-27 2008-12-15 Janssen Pharmaceutica Nv Derivados de indole úteis como moduladores do receptor da progesterona
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
DE102008057230A1 (de) * 2008-11-11 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
EP3205648A1 (en) 2010-06-10 2017-08-16 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
EP2791132A4 (en) 2011-12-14 2015-08-05 Seragon Pharmaceuticals Inc ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
WO2017059139A1 (en) 2015-10-01 2017-04-06 Olema Pharmaceuticals, Inc. TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
DK3386500T3 (da) 2015-12-09 2022-12-12 Univ Illinois Benzothiophen-baserede selektive østrogenreceptor ned-regulatorer
WO2017197046A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. C3-carbon linked glutarimide degronimers for target protein degradation
CN121974842A (zh) 2016-05-10 2026-05-05 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
CN109562113A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的螺环降解决定子体
CN109562107A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的杂环降解决定子体
CN109789143A (zh) 2016-07-01 2019-05-21 G1治疗公司 基于嘧啶的抗增殖剂
WO2018081168A2 (en) 2016-10-24 2018-05-03 The Board Of Trustees Of The University Of Illinois Benzothiophene-based selective mixed estrogen receptor downregulators
JP7229162B2 (ja) 2017-01-06 2023-02-27 ジー１ セラピューティクス， インコーポレイテッド 癌の治療に対する併用療法
KR20190117582A (ko) 2017-02-10 2019-10-16 쥐원 쎄라퓨틱스, 인크. 벤조티오펜 에스트로겐 수용체 조정제
EP4717317A3 (en) 2017-06-20 2026-06-03 C4 Therapeutics, Inc. N/o-linked degrons and degronimers for protein degradation
EP3645001B1 (en) 2017-06-29 2024-07-03 G1 Therapeutics, Inc. Morphic forms of git38 and methods of manufacture thereof
EP3897631A4 (en) 2018-12-20 2022-11-23 C4 Therapeutics, Inc. TARGETED PROTEIN BREAKDOWN
CA3144791A1 (en) 2019-07-07 2021-01-14 Olema Pharmaceuticals, Inc. Regimens of estrogen receptor antagonists
EP4681715A3 (en) 2019-12-20 2026-01-28 C4 Therapeutics, Inc. Isoindolinone and indazole compounds for the degradation of egfr
CN119823124A (zh) 2020-03-05 2025-04-15 C4医药公司 用于brd9的靶向降解的化合物
EP4164653A4 (en) 2020-06-15 2024-06-19 G1 Therapeutics, Inc. MORPHIC FORMS OF TRILACICLIB AND METHODS OF PREPARING THE SAME
CN116490186B (zh) 2020-08-05 2025-10-31 C4医药公司 用于ret的靶向降解的化合物
BR112023024507A2 (pt) 2021-05-26 2024-02-15 C4 Therapeutics Inc Método para tratar um câncer mediado por receptor do fator de crescimento epidérmico mutante que sofreu metástase para o cérebro ou sistema nervoso central
AU2022290851A1 (en) 2021-06-08 2023-11-23 C4 Therapeutics, Inc. Therapeutics for the degradation of mutant braf
KR20250055538A (ko) 2022-08-03 2025-04-24 브리스톨-마이어스 스큅 컴퍼니 Ret 단백질을 조정하기 위한 화합물
JP2025540906A (ja) 2022-11-04 2025-12-17 ブリストル－マイヤーズ スクイブ カンパニー Ｒｅｔ－ｌｄｄタンパク質阻害剤
KR20250117789A (ko) 2022-11-04 2025-08-05 브리스톨-마이어스 스큅 컴퍼니 Ret-ldd 단백질 분해제
CN122206684A (zh) 2023-06-30 2026-06-12 默克专利有限公司 用于kras蛋白降解的异双功能化合物
WO2026139448A1 (en) 2024-12-23 2026-07-02 Merck Patent Gmbh Heterobifunctional compounds for the degradation of kras protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA716118B (en) * 1970-10-05 1972-05-31 Richardson Merrell Inc Contraception
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
IL120263A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to prevent bone loss-progesterone and estrogen agonists
SK281737B6 (sk) * 1996-04-19 2001-07-10 American Home Products Corporation 2-fenylindolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive

Also Published As

Publication number Publication date
GEP20043290B (en) 2004-07-26
DE69831605D1 (de) 2005-10-20
ZA9810136B (en) 2000-05-05
EP1051179A2 (en) 2000-11-15
AU2003204896B2 (en) 2006-06-15
EP1051179B1 (en) 2005-09-14
HUP0100293A2 (hu) 2001-10-28
DE69831605T2 (de) 2006-06-14
NO20002167D0 (no) 2000-04-27
AU760540B2 (en) 2003-05-15
CA2307210A1 (en) 1999-05-20
EE200000211A (et) 2001-04-16
SK6482000A3 (en) 2000-11-07
BR9813982A (pt) 2000-09-26
TR200001268T2 (tr) 2001-01-22
AU1303199A (en) 1999-05-31
WO1999024027A2 (en) 1999-05-20
CZ294155B6 (cs) 2004-10-13
ES2246541T3 (es) 2006-02-16
PL340623A1 (en) 2001-02-12
HRP20000269A2 (en) 2000-12-31
WO1999024027A3 (en) 1999-07-15
HUP0100293A3 (en) 2002-12-28
JP2001522798A (ja) 2001-11-20
NO20002167L (no) 2000-06-28
NZ503890A (en) 2002-08-28
CZ20001661A3 (cs) 2000-12-13
CN1278732A (zh) 2001-01-03
ATE304359T1 (de) 2005-09-15
ID24568A (id) 2000-07-27
EE04092B1 (et) 2003-08-15
BG104451A (en) 2000-12-29
EA200000492A1 (ru) 2000-10-30
UA68365C2 (en) 2004-08-16
IL135621A0 (en) 2001-05-20
AR016667A1 (es) 2001-07-25

Similar Documents

Publication Publication Date Title
NO20002167D0 (no) Anti-østrogen pluss progestin-inneholdende orale befruktningshindrende midler
ID20233A (id) Komposisi oral
DE59802860D1 (de) Desinfektionsmittel
EP1072253A4 (en) PREPARATIONS TO BE ORALED
DE59506139D1 (de) Orale Retard-Präparation
NO20001612D0 (no) Oralt preparat
MA24473A1 (fr) Formulations
DE59802830D1 (de) Orthesengelenk
EP0836470A4 (en) ORAL COMPOSITIONS
DE60007530D1 (de) Oral wirksame androgene
DE69827710D1 (de) Kippbecken-WC
ATE218540T1 (de) Mikrobiozide n-sulfonylglycin- alkynyloxyphenethylamid-derivate
ITMI991826A0 (it) Nuova formulazione orale
DE69821845D1 (de) Ostomievorrichtung
DE60032510D1 (de) Kondom
DK1334725T3 (da) Östroprogestativt antikonceptionsmiddel
ID20466A (id) Komposisi oral
ID19885A (id) Tisu lembab
DE69907677D1 (de) Brennstoff-luft-mischgerät
DK0853933T3 (da) Ostomikobling
DE69832127D1 (de) Wässrige Siliconzusammensetzung
ID20328A (id) Toilet
EP0998924A4 (en) ANTI-TUMOR ACTIVE
DE69804179D1 (de) Photoempfindliche Zusammensetzung
DE59702106D1 (de) Knabber